DiaMedica Therapeutics Inc.

DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401040

Price chart

Open-market purchases and sales by DMAC insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Dec 8, 20255:15 PM ETNov 17 – Nov 25, 2025TRILL AB and 1 other10% OwnerPPurchaseCommon Shares+1.06M$7.1908+$7.63M8.83M+13.7%SEC
Sep 4, 20252:29 PM ETAug 13 – Aug 27, 2025TRILL AB and 1 other10% OwnerPPurchaseCommon Shares+1M$5.9581+$5.96M7.76M+14.8%SEC
Jul 25, 20256:54 PM ETJul 23, 2025TRILL AB and 1 other10% OwnerPPurchaseCommon Shares+1.54M$3.50+$5.4M6.76M+29.5%SEC
Jul 25, 20255:49 PM ETJul 23, 2025TomEnterprise AB and 2 others10% OwnerPPurchaseCommon Shares+2.86M$3.50+$10M8.38M+51.7%SEC
Jul 25, 2025Jul 23, 2025JACINTO RICHARD II10% OwnerPPurchaseVoting Common Shares, no par value per share+400K$3.50+$1.4M4.96M+8.8%SEC

The largest institutional positions in DMAC at the end of Q2 2026.

Institutions holding DMAC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
COOPERMAN LEON G3,450,000$24.29M0.68%+1,430,000+70.8%Added
BlackRock, Inc.2,252,285$15.86M0.00%+396,098+21.3%Added
GEODE CAPITAL MANAGEMENT, LLC894,115$6.3M0.00%+113,599+14.6%Added
MILLENNIUM MANAGEMENT LLC845,309$5.95M0.00%−90,283−9.6%Reduced
STATE STREET CORP646,743$4.55M0.00%+2,532+0.4%Added